Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC)

计划入组 46 人 · 首次发布于 2007 年 6 月 6 日

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma

计划入组 57 人 · 首次发布于 2007 年 6 月 8 日

Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour

计划入组 48 人 · 首次发布于 2009 年 4 月 8 日

CTGF (FibroGen)

111In-hEGF

vMyx-hTNF

Ebenbuild Secures €2.3 Million EIC Grant to Advance Digital Twin Platform for Respiratory Drug Development

Smartbax Secures €4.7M to Advance Novel Antibiotic Compounds Against Multi-Drug Resistant Bacteria

HMNC Brain Health Secures $50 Million Series B Financing and European Partnership with MEDICE for Precision Psychiatry Pipeline